 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- HBM7008 / Harbour BioMed, HBM7004 / Harbour BioMed
HBM7008 (B7H4x4-1BB HBICE) Synergizes HBM7004 (B7H4xCD3 HBICE) for Solid Tumor Therapy (Hall C) - Oct 6, 2022 - Abstract #SITC2022SITC_1170;
Ethics Approval The cancer tissue microarray was purchased from Fanpu Biotech, Inc. The company ensured ethical approval from the patients, and patient consent for publication.